Disc Medicine, Inc. — Director's Dealing 2021

Feb 19, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Gemini Therapeutics, Inc. /DE (GMTX)
CIK: 0001816736
Period of Report: 2021-02-12

Reporting Person: Piekos Brian (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$12.66	2031-02-03	Common Stock (43580)		Direct

Footnotes

F1: This option shall vest and become exercisable 25% of the shares vesting on the one-year anniversary of the Vesting Start Date, February 4, 2022, and the remainder vesting ratably on a quarterly basis over the following 12 quarters, subject to continued employment.